{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:49:25Z","timestamp":1793299765719,"version":"4.5.0"},"reference-count":294,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.prp.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T23:21:18Z","timestamp":1462490478000},"page":"583-597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"title":["Lobular breast cancer: Clinical, molecular and morphological characteristics"],"prefix":"10.1016","volume":"212","author":[{"given":"Matthias","family":"Christgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Steinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elna","family":"K\u00fchnle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"L\u00e4nger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Gluz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Kreipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2016.05.002_bib0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0010","series-title":"Les Tumeurs du sein","author":"Cornil","year":"1908"},{"key":"10.1016\/j.prp.2016.05.002_bib0015","series-title":"Pathology of Tumours","first-page":"208","article-title":"Epithelial tumours of the breast","author":"Willis","year":"1948"},{"key":"10.1016\/j.prp.2016.05.002_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000478-197809000-00001","article-title":"Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years","volume":"2","author":"Rosen","year":"1978","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0025","first-page":"491","article-title":"Lobular carcinoma in situ: a rare form of mammary cancer","volume":"17","author":"Foote","year":"1941","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1097-0142(195203)5:2<259::AID-CNCR2820050210>3.0.CO;2-G","article-title":"Chronology of lobular carcinoma of the breast; report of a case","volume":"5","author":"Godwin","year":"1952","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0035","first-page":"987","article-title":"Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma","volume":"142","author":"Gamallo","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0040","first-page":"1731","article-title":"Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas","volume":"143","author":"Moll","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0045","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1002\/j.1460-2075.1995.tb00301.x","article-title":"E-cadherin is a tumour\/invasion suppressor gene mutated in human lobular breast cancers","volume":"14","author":"Berx","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.prp.2016.05.002_bib0050","first-page":"1919","article-title":"E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain","volume":"13","author":"Berx","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2016.05.002_bib0055","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1002\/1097-0142(20000601)88:11<2561::AID-CNCR19>3.0.CO;2-X","article-title":"Changing incidence rate of invasive lobular breast carcinoma among older women","volume":"88","author":"Li","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0060","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.11032","article-title":"Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland","volume":"104","author":"Verkooijen","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0065","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-04-0849","article-title":"Age-specific incidence rates of in situ breast carcinomas by histologic type: 1980\u20132001","volume":"14","author":"Li","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.prp.2016.05.002_bib0070","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1245\/s10434-013-3121-4","article-title":"Trends in incidence and management of lobular carcinoma in situ: a population-based analysis","volume":"20","author":"Portschy","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ijc.22625","article-title":"Uncommon breast tumors in perspective: incidence: treatment and survival in the Netherlands","volume":"121","author":"Louwman","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0080","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1158\/1055-9965.EPI-07-0546","article-title":"Changes in breast cancer incidence rates in the United States by histologic subtype and race\/ethnicity, 1995\u20132004","volume":"16","author":"Li","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.prp.2016.05.002_bib0085","doi-asserted-by":"crossref","first-page":"e0138556","DOI":"10.1371\/journal.pone.0138556","article-title":"Hormone replacement therapy, likely neither angel nor demon","volume":"10","author":"Wachtel","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2016.05.002_bib0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3322\/caac.21321","article-title":"Cancer statistics: breast cancer in situ","volume":"65","author":"Ward","year":"2015","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.prp.2016.05.002_bib0095","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ijc.21236","article-title":"Lobular breast cancer: excess familiality observed in the Utah Population Database","volume":"117","author":"Allen-Brady","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0100","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cam4.474","article-title":"Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort study","volume":"2015","author":"Suhrke","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2016.05.002_bib0105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10549-014-2960-4","article-title":"Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55\u201374 years of age","volume":"145","author":"Li","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0110","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/jnci\/djq316","article-title":"Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study","volume":"102","author":"Li","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2016.05.002_bib0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/1471-2407-11-497","article-title":"Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer","volume":"11","author":"Ellberg","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0120","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/cncr.25728","article-title":"Late age at first full term birth is strongly associated with lobular breast cancer","volume":"117","author":"Newcomb","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0125","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ijc.11465","article-title":"Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65\u201379 years of age","volume":"107","author":"Li","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0130","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","article-title":"Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118964 women with breast cancer from 117 epidemiological studies","volume":"13","author":"CGHFBC","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0135","doi-asserted-by":"crossref","first-page":"e1004285","DOI":"10.1371\/journal.pgen.1004285","article-title":"Genetic predisposition to in situ and invasive lobular carcinoma of the breast","volume":"10","author":"Sawyer","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.prp.2016.05.002_bib0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1440-1827.1998.tb03917.x","article-title":"Clinicopathologic features and incidence of invasive lobular carcinoma in Japanese women","volume":"48","author":"Fu","year":"1998","journal-title":"Pathol. Int."},{"key":"10.1016\/j.prp.2016.05.002_bib0145","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/modpathol.3800408","article-title":"Predominance of high-grade pathway in breast cancer development of Middle East women","volume":"18","author":"Al-Kuraya","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jso.21110","article-title":"Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996\u20132006) using nationwide breast cancer registration on-line program: biannual update","volume":"98","author":"Ko","year":"2008","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0155","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ijc.28691","article-title":"Breast cancer survival in Ethiopia: a cohort study of 1,070 women","volume":"135","author":"Kantelhardt","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0160","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/bcr1839","article-title":"Recent breast cancer trends among Asian\/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype","volume":"9","author":"Hausauer","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0165","first-page":"601","article-title":"Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older","volume":"11","author":"Li","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.prp.2016.05.002_bib0170","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1354\/vp.43-4-471","article-title":"Hyperplastic and neoplastic lesions of the mammary gland in macaques","volume":"43","author":"Wood","year":"2006","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0175","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcpa.2010.08.015","article-title":"Canine invasive lobular carcinoma of the mammary gland: morphological and immunohistochemical characterizations of three cases","volume":"144","author":"Ressel","year":"2011","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0300985810393258","article-title":"Classification and grading of canine mammary tumors","volume":"48","author":"Goldschmidt","year":"2011","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1018712905244","article-title":"The comparative pathology of human and mouse mammary glands","volume":"4","author":"Cardiff","year":"1999","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.prp.2016.05.002_bib0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9440(10)65129-2","article-title":"Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation","volume":"155","author":"Keller","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0195","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","article-title":"Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families","volume":"121","author":"Pharoah","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2016.05.002_bib0200","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1158\/1078-0432.CCR-05-0247","article-title":"Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management","volume":"11","author":"Suriano","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0205","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jmg.2004.018275","article-title":"Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria","volume":"41","author":"Brooks-Wilson","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.prp.2016.05.002_bib0210","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1001\/jama.297.21.2360","article-title":"Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer","volume":"297","author":"Kaurah","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.prp.2016.05.002_bib0215","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.26398","article-title":"CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling","volume":"131","author":"Kluijt","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0220","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.clbc.2013.10.007","article-title":"Lobular breast cancer in a CDH1 splice site mutation carrier: case report and review of the literature","volume":"14","author":"McVeigh","year":"2014","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0225","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/gcc.22155","article-title":"Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome","volume":"53","author":"Molinaro","year":"2014","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0230","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/bjc.2013.792","article-title":"Germline CDH1 mutations in bilateral lobular carcinoma in situ","volume":"110","author":"Petridis","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0235","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/jmedgenet-2012-101472","article-title":"CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study","volume":"50","author":"Benusiglio","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.prp.2016.05.002_bib0240","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.gene.2012.01.028","article-title":"16q22.1 microdeletion detected by array-CGH in a family with mental retardation and lobular breast cancer","volume":"498","author":"Palka Bayard de Volo","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.prp.2016.05.002_bib0245","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/cncr.25876","article-title":"Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer","volume":"117","author":"Xie","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10689-007-9172-6","article-title":"Hereditary diffuse gastric cancer: association with lobular breast cancer","volume":"7","author":"Schrader","year":"2008","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0255","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/jmg.2007.051268","article-title":"Germline E-cadherin mutations in familial lobular breast cancer","volume":"44","author":"Masciari","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.prp.2016.05.002_bib0260","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.11197","article-title":"Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability","volume":"106","author":"Sarrio","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0265","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1\/2 (CIMBA)","volume":"21","author":"Mavaddat","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.prp.2016.05.002_bib0270","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","article-title":"Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast cancer linkage consortium","volume":"349","author":"Breast-Cancer-Linkage-Consortium","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2016.05.002_bib0275","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.bjc.6601424","article-title":"Germline truncating mutations in both MSH2 and BRCA2 in a single kindred","volume":"90","author":"Thiffault","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0280","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1034\/j.1399-0004.2001.590606.x","article-title":"Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer","volume":"59","author":"Chappuis","year":"2001","journal-title":"Clin. Genet."},{"key":"10.1016\/j.prp.2016.05.002_bib0285","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N","article-title":"The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study","volume":"83","author":"Armes","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0290","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1005830230664","article-title":"BRCA2 hereditary breast cancer pathophenotype","volume":"44","author":"Marcus","year":"1997","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0295","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10549-011-1635-7","article-title":"Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer","volume":"132","author":"Domagala","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0300","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1158\/1078-0432.CCR-06-0158","article-title":"CHEK2-positive breast cancers in young Polish women","volume":"12","author":"Cybulski","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10549-004-3778-2","article-title":"Pathology of breast cancer in women with constitutional CHEK2 mutations","volume":"90","author":"Huzarski","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0310","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10549-012-1993-9","article-title":"Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort","volume":"133","author":"Masciari","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0315","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/bcr2626","article-title":"Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations","volume":"12","author":"Banneau","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0320","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/jnci\/91.23.2020","article-title":"Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers","volume":"91","author":"Porter","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2016.05.002_bib0325","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.breast.2014.12.009","article-title":"Digital mammography screening in Germany: impact of age and histological subtype on program sensitivity","volume":"24","author":"Heidinger","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.prp.2016.05.002_bib0330","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3091","article-title":"Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study","volume":"14","author":"Nederend","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0335","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnci\/djr138","article-title":"Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program","volume":"103","author":"Kirsh","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2016.05.002_bib0340","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/jnci\/djn224","article-title":"Comparing screening mammography for early breast cancer detection in Vermont and Norway","volume":"100","author":"Hofvind","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2016.05.002_bib0345","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejca.2012.07.027","article-title":"Clinicopathological differences between breast cancer in patients with primary metastatic disease and those without: a multicentre study","volume":"49","author":"Barinoff","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0350","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/cncr.20204","article-title":"Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma","volume":"100","author":"Jimeno","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0355","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/annonc\/mdm507","article-title":"Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells","volume":"19","author":"Bidard","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0360","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jss.2012.03.014","article-title":"Invasive lobular carcinoma predicts micrometastasis in breast cancer","volume":"177","author":"Gainer","year":"2012","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0365","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1186\/1471-2407-12-616","article-title":"Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study","volume":"12","author":"Synnestvedt","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0370","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejso.2014.09.004","article-title":"Surgical management of lobular carcinoma from a national screening program: a retrospective analysis","volume":"41","author":"Sharma","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0375","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-014-2861-6","article-title":"Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma","volume":"144","author":"Loibl","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0380","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejso.2013.02.007","article-title":"Clinical-pathologic features: long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC)","volume":"39","author":"Biglia","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0385","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.breast.2013.06.001","article-title":"The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients","volume":"22","author":"Korhonen","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.prp.2016.05.002_bib0390","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10549-012-2160-z","article-title":"Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences","volume":"135","author":"Kwast","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0395","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/annonc\/mdr461","article-title":"Outcome of special types of luminal breast cancer","volume":"23","author":"Colleoni","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0400","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-012-2233-z","article-title":"Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer","volume":"136","author":"Lips","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0405","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1245\/s10434-011-1907-9","article-title":"Lobular Breast cancer: same survival and local control compared with ductal cancer: but should both Be treated the same way? Analysis of an institutional database over a 10-year period","volume":"19","author":"Fortunato","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0410","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jclinpath-2011-200151","article-title":"Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast","volume":"64","author":"Fernandez","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0415","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/1471-2407-10-664","article-title":"The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study","volume":"10","author":"Jung","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0420","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1245\/s10434-010-0953-z","article-title":"Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes","volume":"17","author":"Wasif","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0425","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1477-7819-8-34","article-title":"Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a case control study","volume":"8","author":"Lee","year":"2010","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0430","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-008-0112-4","article-title":"Lack of prognostic significance of classic lobular breast carcinoma: a matched: single institution series","volume":"117","author":"Viale","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0435","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","article-title":"Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials","volume":"26","author":"Pestalozzi","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0440","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejca.2007.10.009","article-title":"Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes","volume":"44","author":"Rakha","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0445","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/bcr767","article-title":"Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome","volume":"6","author":"Arpino","year":"2004","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0450","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/bjc.1997.540","article-title":"Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma","volume":"76","author":"Toikkanen","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0455","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8","article-title":"Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns","volume":"77","author":"Sastre-Garau","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0460","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B","article-title":"Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma","volume":"73","author":"Silverstein","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0465","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cam4.331","article-title":"High frequency of lobular breast cancer in distant metastases to the orbit","volume":"4","author":"Raap","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2016.05.002_bib0470","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-014-4175-7","article-title":"Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands","volume":"22","author":"Truin","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0475","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1245\/s10434-015-4570-8","article-title":"Surgical options and locoregional recurrence in patients diagnosed with invasive lobular carcinoma of the Breast","volume":"22","author":"Sagara","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0480","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-009-0616-6","article-title":"The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast","volume":"119","author":"Mann","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0485","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3816\/CBC.2010.n.007","article-title":"Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma","volume":"10","author":"Silberfein","year":"2010","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0490","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/bjs.1800821023","article-title":"Lobular carcinoma of the breast can be managed by breast-conserving therapy","volume":"82","author":"Holland","year":"1995","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.prp.2016.05.002_bib0495","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10549-015-3273-y","article-title":"Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin","volume":"149","author":"Braunstein","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0500","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.breast.2014.08.011","article-title":"Re-resection rates and risk characteristics following breast conserving surgery for breast cancer and carcinoma in situ: a single-centre study of 1575 consecutive cases","volume":"23","author":"Kryh","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.prp.2016.05.002_bib0505","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1177\/000313481307901034","article-title":"Rate of re-excision after breast-conserving surgery for invasive lobular carcinoma","volume":"79","author":"Wanis","year":"2013","journal-title":"Am. Surg."},{"key":"10.1016\/j.prp.2016.05.002_bib0510","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1245\/s10434-007-9777-x","article-title":"Predictors of re-excision among women undergoing breast-conserving surgery for cancer","volume":"15","author":"Waljee","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0515","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10549-006-9431-5","article-title":"Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer","volume":"105","author":"van den Broek","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0520","article-title":"Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer","author":"Petrelli","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0525","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/bjc.2012.557","article-title":"Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas","volume":"108","author":"Delpech","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0530","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/tbj.12006","article-title":"Pathologic tumor response of invasive lobular carcinoma to neo-adjuvant chemotherapy","volume":"18","author":"Joh","year":"2012","journal-title":"Breast J."},{"key":"10.1016\/j.prp.2016.05.002_bib0535","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1245\/s10434-010-1008-1","article-title":"The relevance of Breast cancer subtypes in the outcome of neoadjuvant chemotherapy","volume":"17","author":"Straver","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0540","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cncr.22981","article-title":"Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy","volume":"110","author":"Goldstein","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0545","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/annonc\/mdl114","article-title":"Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution","volume":"17","author":"Tubiana-Hulin","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0550","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1200\/JCO.2005.03.111","article-title":"Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes","volume":"23","author":"Cristofanilli","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0555","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejca.2003.08.015","article-title":"The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile","volume":"40","author":"Mathieu","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0560","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/ejso.2002.1404","article-title":"Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma","volume":"29","author":"Cocquyt","year":"2003","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0565","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1158\/0008-5472.CAN-14-0620","article-title":"Molecular changes in lobular breast cancers in response to endocrine therapy","volume":"74","author":"Arthur","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0570","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10549-011-1735-4","article-title":"Invasive lobular carcinoma: response to neoadjuvant letrozole therapy","volume":"130","author":"Dixon","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0575","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-05-2127","article-title":"Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer","volume":"12","author":"Dowsett","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0580","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1745-6215-14-261","volume":"14","author":"Hofmann","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.prp.2016.05.002_bib0585","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1158\/0008-5472.CAN-13-2779","article-title":"Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response","volume":"74","author":"Sikora","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0590","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13058-015-0517-z","article-title":"Lobular breast cancer: molecular basis, mouse and cellular models","volume":"17","author":"Christgen","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0595","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0277-5379(87)90344-0","article-title":"Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival","volume":"23","author":"Smith","year":"1987","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0600","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jcp.2005.027185","article-title":"Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial","volume":"58","author":"Jirstrom","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0605","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejca.2012.07.026","article-title":"Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer\u2014a TEAM study analysis","volume":"49","author":"van de Water","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0610","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO.2015.60.8133","article-title":"Relative effectiveness of letrozole compared with tamoxifen for patients with lobular carcinoma in the BIG 1\u201398 trial","volume":"33","author":"Metzger Filho","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"Suppl","key":"10.1016\/j.prp.2016.05.002_bib0615","first-page":"S2","article-title":"al advantage of anastrozol compared to tamoxifen for lobular breast cancer in the ABCSG-8 study","volume":"75","author":"Knauer","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0620","unstructured":"A. Scharl, Diagnosis and therapy of patients with primary and metastatic breast cancer. Munich: Zuckschwerdt Verlag (2015)."},{"key":"10.1016\/j.prp.2016.05.002_bib0625","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10549-012-2002-z","article-title":"Invasive lobular breast cancer: subtypes and outcome","volume":"133","author":"Iorfida","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0630","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-008-0007-4","article-title":"The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology","volume":"114","author":"Rakha","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0635","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/cncr.23811","article-title":"Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution","volume":"113","author":"Orvieto","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0640","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/labinvest.2012.126","article-title":"IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes","volume":"92","author":"Christgen","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.prp.2016.05.002_bib0645","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1470-2045(06)71011-7","article-title":"Primary systemic chemotherapy of invasive lobular carcinoma of the breast","volume":"8","author":"Katz","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0650","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/path.2495","article-title":"Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer","volume":"217","author":"Christgen","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0655","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D","article-title":"Mutations of the human E-cadherin (CDH1) gene","volume":"12","author":"Berx","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.prp.2016.05.002_bib0660","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2016.05.002_bib0665","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/his.12253","article-title":"A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary","volume":"64","author":"Kommoss","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2016.05.002_bib0670","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1056\/NEJMoa0902542","article-title":"Mutation of FOXL2 in granulosa-cell tumors of the ovary","volume":"360","author":"Shah","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2016.05.002_bib0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007988","article-title":"The specificity of the FOXL2 c 402C > G somatic mutation: a survey of solid tumors","volume":"4","author":"Schrader","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2016.05.002_bib0680","article-title":"An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular Carcinomas","author":"McCart Reed","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0685","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/path.2541","article-title":"Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia","volume":"218","author":"Zou","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0690","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.prp.2016.05.002_bib0695","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/gcc.22007","article-title":"Oncogenic PIK3CA mutations in lobular breast cancer progression","volume":"52","author":"Christgen","year":"2013","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0700","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10549-011-1518-y","article-title":"Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes","volume":"132","author":"Boyault","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0705","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.prp.2016.05.002_bib0710","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature11143","article-title":"Whole-genome analysis informs breast cancer response to aromatase inhibition","volume":"486","author":"Ellis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.prp.2016.05.002_bib0715","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/PAS.0b013e3181f01916","article-title":"Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast","volume":"34","author":"Rakha","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0720","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1038\/onc.2008.158","article-title":"Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles","volume":"27","author":"Bertucci","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2016.05.002_bib0725","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0b013e318158d6c5","article-title":"Aberrant expression of E-cadherin in lobular carcinomas of the breast","volume":"32","author":"Da Silva","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0730","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5507\/bp.2007.010","article-title":"Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas","volume":"151","author":"Turashvili","year":"2007","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub."},{"key":"10.1016\/j.prp.2016.05.002_bib0735","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/1078-0432.CCR-06-1164","article-title":"FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas","volume":"12","author":"Reis-Filho","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0740","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2407-6-48","article-title":"CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer","volume":"6","author":"Caldeira","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0745","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/sj.onc.1207439","article-title":"Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions","volume":"23","author":"Sarrio","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2016.05.002_bib0750","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ijc.10176","article-title":"CDH1 mutations are present in both ductal and lobular breast cancer: but promoter allelic variants show no detectable breast cancer risk","volume":"98","author":"Lei","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0755","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.1208","article-title":"Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast","volume":"92","author":"Droufakou","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0760","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.bjc.6690815","article-title":"Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer","volume":"81","author":"Huiping","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0765","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9","article-title":"Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ","volume":"183","author":"De Leeuw","year":"1997","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0770","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10549-011-1860-0","article-title":"Cadherin-catenin complex dissociation in lobular neoplasia of the breast","volume":"132","author":"Morrogh","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0775","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist a master regulator of morphogenesis, plays an essential role in tumor metastasis","volume":"117","author":"Yang","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.prp.2016.05.002_bib0780","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ijc.11508","article-title":"DNA methylation of RASSF1A, HIN-1 RAR-beta, cyclin D2 and Twist in in situ and invasive lobular breast carcinoma","volume":"107","author":"Fackler","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0785","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10549-009-0545-4","article-title":"Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations","volume":"122","author":"Hollestelle","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0790","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/path.4152","article-title":"An alpha-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer","volume":"229","author":"Majewski","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0795","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0800","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2005.02156.x","article-title":"E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance","volume":"46","author":"Rakha","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2016.05.002_bib0805","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO;2-3","article-title":"An immunohistochemical examination of the expression of E-cadherin alpha- and beta\/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer","volume":"187","author":"Gonzalez","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0810","first-page":"4665","article-title":"p53 mutations and histological type of invasive breast carcinoma","volume":"53","author":"Marchetti","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0815","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bjc.6600556","article-title":"Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence","volume":"87","author":"Coradini","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0820","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1078-0432.CCR-05-1029","article-title":"The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer","volume":"12","author":"Olivier","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0825","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1675","article-title":"TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer","volume":"9","author":"Langerod","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0830","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13402-012-0071-y","article-title":"p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast","volume":"35","author":"Ercan","year":"2012","journal-title":"Cell Oncol. (Dordr.)"},{"key":"10.1016\/j.prp.2016.05.002_bib0835","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/path.1908","article-title":"PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma","volume":"208","author":"Buttitta","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0840","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1158\/1078-0432.CCR-07-0266","article-title":"Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas","volume":"13","author":"Barbareschi","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0845","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-06-0267","article-title":"Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women","volume":"13","author":"Maruyama","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0850","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1158\/1078-0432.CCR-09-0632","article-title":"PIK3CA mutation associates with improved outcome in breast cancer","volume":"15","author":"Kalinsky","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0855","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PDM.0b013e31818e5fa4","article-title":"PIK3CA in breast carcinoma: a mutational analysis of sporadic and hereditary cases","volume":"18","author":"Michelucci","year":"2009","journal-title":"Diagn. Mol. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0860","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00432-010-0824-9","article-title":"Alterations in p53, BRCA1 ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer","volume":"136","author":"Bozhanov","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib0865","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nature08489","article-title":"Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution","volume":"461","author":"Shah","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.prp.2016.05.002_bib0870","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1158\/1078-0432.CCR-13-0295","article-title":"Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations","volume":"19","author":"Ross","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0875","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10549-015-3336-0","article-title":"Frequent alterations of HER2 through mutation amplification, or overexpression in pleomorphic lobular carcinoma of the breast","volume":"150","author":"Lien","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib0880","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1172\/JCI41695","article-title":"Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance","volume":"121","author":"Schackmann","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2016.05.002_bib0885","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00428-005-0003-6","article-title":"Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma","volume":"447","author":"Riva","year":"2005","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2016.05.002_bib0890","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/modpathol.2011.54","article-title":"Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses\u2019 Health Study","volume":"24","author":"Collins","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0895","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/(SICI)1096-9896(199808)185:4<394::AID-PATH117>3.0.CO;2-S","article-title":"Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis","volume":"185","author":"Lee","year":"1998","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0900","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1158\/0008-5472.CAN-09-3746","article-title":"FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer","volume":"70","author":"Turner","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0905","first-page":"1421","article-title":"Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal hyperplastic, and neoplastic human breast","volume":"53","author":"Clezardin","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0910","first-page":"163","article-title":"Altered endoplasmic reticulum calcium pump expression during breast tumorigenesis","volume":"5","author":"Papp","year":"2011","journal-title":"Breast Cancer (Auckl.)"},{"key":"10.1016\/j.prp.2016.05.002_bib0915","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mc.10069","article-title":"CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast","volume":"35","author":"Mercapide","year":"2002","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.prp.2016.05.002_bib0920","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/modpathol.2010.189","article-title":"P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer","volume":"24","author":"Turashvili","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0925","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135442","article-title":"The expression of the zonula adhaerens protein PLEKHA7 is strongly decreased in high grade ductal and lobular breast carcinomas","volume":"10","author":"Tille","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2016.05.002_bib0930","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/path.2978","article-title":"Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity","volume":"226","author":"Giricz","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0935","first-page":"1533","article-title":"Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma","volume":"4","author":"Dexter","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0940","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037864","article-title":"Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer","volume":"7","author":"Vermeulen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2016.05.002_bib0945","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1073\/pnas.1323719111","article-title":"Differential expression of estrogen receptor alpha beta1, and beta2 in lobular and ductal breast cancer","volume":"111","author":"Huang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2016.05.002_bib0950","first-page":"6634","article-title":"Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype","volume":"62","author":"Lehmann","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0955","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s13402-013-0143-7","article-title":"Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer","volume":"36","author":"Vlug","year":"2013","journal-title":"Cell Oncol. (Dordr.)"},{"key":"10.1016\/j.prp.2016.05.002_bib0960","first-page":"3976","article-title":"Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas","volume":"55","author":"Aldaz","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0965","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ijc.2910640409","article-title":"Microsatellite instability and pathological aspects of breast cancer","volume":"64","author":"Contegiacomo","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0970","first-page":"241","article-title":"Microsatellite instability is correlated with lymph node-positive breast cancer","volume":"3","author":"De Marchis","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib0975","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.1453","article-title":"MSI-low: a real phenomenon which varies in frequency among cancer types","volume":"201","author":"Halford","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0980","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.humpath.2015.05.001","article-title":"Telomere length alterations unique to invasive lobular carcinoma","volume":"46","author":"Heaphy","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib0985","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1098-2264(199812)23:4<300::AID-GCC4>3.0.CO;2-N","article-title":"Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer","volume":"23","author":"Flagiello","year":"1998","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib0990","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1242\/dmm.018648","article-title":"Nuclear p120-catenin regulates the anoikis resistance of mouse lobular breast cancer cells through Kaiso-dependent Wnt11 expression","volume":"8","author":"van de Ven","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.prp.2016.05.002_bib0995","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/embr.201337868","article-title":"p120-catenin differentially regulates cell migration by Rho-dependent intracellular and secreted signals","volume":"15","author":"Epifano","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.prp.2016.05.002_bib1000","first-page":"278","article-title":"Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling","volume":"61","author":"van de Wetering","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1005","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/hmg\/ddr469","article-title":"E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2","volume":"21","author":"Ferreira","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.prp.2016.05.002_bib1010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073062","article-title":"Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1\/E-cadherin?","volume":"8","author":"Karch","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2016.05.002_bib1015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/epi.14.74","article-title":"The CpG island methylator phenotype in breast cancer is associated with the lobular subtype","volume":"7","author":"Roessler","year":"2014","journal-title":"Epigenomics"},{"key":"10.1016\/j.prp.2016.05.002_bib1020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13402-015-0241-9","article-title":"Methylation biomarkers for pleomorphic lobular breast cancer\u2014a short report","volume":"38","author":"Moelans","year":"2015","journal-title":"Cell Oncol. (Dordr.)"},{"key":"10.1016\/j.prp.2016.05.002_bib1025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<513::AID-IJC6>3.0.CO;2-6","article-title":"Genetic alterations in lobular breast cancer by comparative genomic hybridization","volume":"74","author":"Nishizaki","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1097-0215(20000520)89:3<305::AID-IJC15>3.0.CO;2-8","article-title":"Patterns of chromosomal imbalances in invasive breast cancer","volume":"89","author":"Richard","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH745>3.0.CO;2-N","article-title":"Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization","volume":"193","author":"Gunther","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1040","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1158\/0008-5472.CAN-04-1992","article-title":"Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes","volume":"64","author":"Loo","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/1078-0432.CCR-05-1633","article-title":"High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer","volume":"12","author":"Stange","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1050","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1038\/sj.onc.1209659","article-title":"A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH","volume":"25","author":"Roylance","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2016.05.002_bib1055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2358","article-title":"Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas","volume":"215","author":"Simpson","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.1691","article-title":"Molecular evolution of breast cancer","volume":"205","author":"Simpson","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1065","article-title":"Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt\/mTOR signaling","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2016.05.002_bib1070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/emmm.201100121","article-title":"ZNF703 gene amplification at 8p12 specifies luminal B breast cancer","volume":"3","author":"Sircoulomb","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.prp.2016.05.002_bib1075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/emmm.201100122","article-title":"ZNF703 is a common luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium","volume":"3","author":"Holland","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.prp.2016.05.002_bib1080","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/bjc.2012.351","article-title":"BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib","volume":"107","author":"Godinho","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1085","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/sj.bjc.6605884","article-title":"Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer","volume":"103","author":"Godinho","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136845","article-title":"Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) drives proliferation of IPH-926 lobular carcinoma cells","volume":"10","author":"van Agthoven","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2016.05.002_bib1095","first-page":"7167","article-title":"Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis","volume":"63","author":"Korkola","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1100","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1091\/mbc.E03-11-0786","article-title":"Different gene expression patterns in invasive lobular and ductal carcinomas of the breast","volume":"15","author":"Zhao","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.prp.2016.05.002_bib1105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2407-7-55","article-title":"Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis","volume":"7","author":"Turashvili","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1110","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrclinonc.2009.166","article-title":"Histological and molecular types of breast cancer: is there a unifying taxonomy","volume":"6","author":"Weigelt","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/cncr.24805","article-title":"Gene expression signatures in breast cancer distinguish phenotype characteristics histologic subtypes, and tumor invasiveness","volume":"116","author":"Pedraza","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1120","article-title":"Utility of oncotype DX risk assessment in patients with invasive lobular carcinoma","author":"Tsai","year":"2015","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1125","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/onc.2011.301","article-title":"A refined molecular taxonomy of breast cancer","volume":"31","author":"Guedj","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2016.05.002_bib1130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10549-010-0897-9","article-title":"A gene expression signature identifies two prognostic subgroups of basal breast cancer","volume":"126","author":"Sabatier","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib1135","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-10-1282","article-title":"A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer","volume":"16","author":"Nielsen","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.2407","article-title":"Refinement of breast cancer classification by molecular characterization of histological special types","volume":"216","author":"Weigelt","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1145","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/02841868809091779","article-title":"Quality control of patho-anatomical diagnosis of carcinoma of the breast","volume":"27","author":"Kiaer","year":"1988","journal-title":"Acta Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/modpathol.3800496","article-title":"Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study","volume":"19","author":"Longacre","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1155","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.ejso.2014.04.007","article-title":"Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma","volume":"40","author":"Wallace","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1160","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1245\/s10434-008-9960-8","article-title":"Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy","volume":"15","author":"Ciocca","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2559.1982.tb02712.x","article-title":"Infiltrating lobular carcinoma of the breast","volume":"6","author":"Dixon","year":"1982","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2016.05.002_bib1170","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000658-196608000-00018","article-title":"Lobular carcinoma of the female breast Report of 73 cases","volume":"164","author":"Newman","year":"1966","journal-title":"Ann. Surg."},{"key":"10.1016\/j.prp.2016.05.002_bib1175","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T","article-title":"Lobular neoplasia (so-called lobular carcinoma in situ) of the breast","volume":"42","author":"Haagensen","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1180","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.arcmed.2010.08.010","article-title":"Florid lobular intraepithelial neoplasia with signet ring cells: central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma","volume":"41","author":"Alvarado-Cabrero","year":"2010","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1185","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00428-001-0541-5","article-title":"Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications","volume":"440","author":"Bratthauer","year":"2002","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2016.05.002_bib1190","series-title":"World Health Organzation Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs","author":"Tavassoli","year":"2003"},{"key":"10.1016\/j.prp.2016.05.002_bib1195","series-title":"WHO Classification of Tumours of the Breast","author":"Lakhani","year":"2012"},{"key":"10.1016\/j.prp.2016.05.002_bib1200","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2014-927","article-title":"Targeted capture next generation sequencing of fresh frozen lobular carcinoma in situ and invasive lobular cancer identifies a common repertoire of mutations","volume":"74","author":"Sakr","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1205","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/modpathol.2013.197","article-title":"Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions","volume":"27","author":"Ang","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1210","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/bcr3222","article-title":"Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions","volume":"14","author":"Andrade","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10549-007-9557-0","article-title":"Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer","volume":"107","author":"Aulmann","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib1220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00428-006-0192-7","article-title":"Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast","volume":"449","author":"Morandi","year":"2006","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2016.05.002_bib1225","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/cncr.20273","article-title":"Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma","volume":"100","author":"Hwang","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/mp.54.2.91","article-title":"Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas","volume":"54","author":"Rieger-Christ","year":"2001","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1235","first-page":"4721","article-title":"Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia","volume":"58","author":"Lu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1240","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/bjc.1997.523","article-title":"E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis","volume":"76","author":"Vos","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1245","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and Breast cancer risk","author":"King","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1250","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13014-015-0379-7","article-title":"Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases","volume":"10","author":"Cutuli","year":"2015","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1255","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","article-title":"Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study","volume":"7","author":"Hartmann","year":"2014","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.prp.2016.05.002_bib1260","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/ijc.28803","article-title":"Is carcinoma in situ a precursor lesion of invasive breast cancer","volume":"135","author":"To","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1265","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejso.2010.05.019","article-title":"Risk of invasive breast cancer after lobular intra-epithelial neoplasia: review of the literature","volume":"36","author":"Ansquer","year":"2010","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1270","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","article-title":"Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance epidemiology, and end results data","volume":"23","author":"Chuba","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1275","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.11883","article-title":"Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ","volume":"100","author":"Fisher","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1280","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/1097-0142(197409)34:3<554::AID-CNCR2820340313>3.0.CO;2-7","article-title":"Lobular carcinoma in situ of the breast. Long-term followup","volume":"34","author":"Wheeler","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1285","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejso.2011.01.009","article-title":"Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast\u2014a review","volume":"37","author":"Hussain","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1290","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/modpathol.2012.221","article-title":"Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy","volume":"26","author":"Chaudhary","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1295","doi-asserted-by":"crossref","first-page":"979","DOI":"10.5858\/2008-132-979-ISENFT","article-title":"Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy? A report of 38 cases and review of the literature","volume":"132","author":"Cangiarella","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2016.05.002_bib1300","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/modpathol.2008.154","article-title":"Caveolin-1 expression in human breast lobular cancer progression","volume":"22","author":"Perrone","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1305","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.molonc.2014.12.005","article-title":"Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion","volume":"9","author":"Andrade","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1310","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/bcr2332","article-title":"Increased levels of active c-Src distinguish invasive from in situ lobular lesions","volume":"11","author":"Zou","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1315","first-page":"2876","article-title":"Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast","volume":"58","author":"Oyama","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1320","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.5858\/arpa.2015-0190-RA","article-title":"Morphologic mimics of invasive lobular carcinoma","volume":"139","author":"Ishikawa","year":"2015","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2016.05.002_bib1325","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.anndiagpath.2009.03.004","article-title":"Histologic grading of invasive lobular carcinoma: does use of a 2-tiered nuclear grading system improve interobserver variability","volume":"13","author":"Adams","year":"2009","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1330","article-title":"Nottingham grades of lobular carcinoma lack the prognostic implications they bear for ductal carcinoma","author":"Wachtel","year":"2010","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.prp.2016.05.002_bib1335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10549-007-9768-4","article-title":"Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast","volume":"111","author":"Rakha","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib1340","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1440-1827.2009.02385.x","article-title":"Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas","volume":"59","author":"Rosa","year":"2009","journal-title":"Pathol. Int."},{"key":"10.1016\/j.prp.2016.05.002_bib1345","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0046-8177(92)90035-2","article-title":"Pleomorphic variant of invasive lobular carcinoma of the breast","volume":"23","author":"Weidner","year":"1992","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1350","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0046-8177(92)90321-S","article-title":"Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation","volume":"23","author":"Eusebi","year":"1992","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1355","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/path.1711450104","article-title":"Ultrastructural and immunohistochemical features of lobular carcinoma of the breast","volume":"145","author":"Nesland","year":"1985","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1360","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2559.1979.tb03029.x","article-title":"Invasive lobular carcinoma of the breast: incidence and variants","volume":"3","author":"Martinez","year":"1979","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2016.05.002_bib1365","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0046-8177(75)80099-2","article-title":"Histologic variants of infiltrating lobular carcinoma of the breast","volume":"6","author":"Fechner","year":"1975","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1370","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/00000478-200412000-00006","article-title":"Tubulolobular carcinoma of the breast: an analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile","volume":"28","author":"Wheeler","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1375","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/modpathol.2012.197","article-title":"Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade","volume":"26","author":"Rakha","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1380","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2559.2012.04230.x","article-title":"Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type","volume":"61","author":"Monhollen","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2016.05.002_bib1385","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.MP.0000073974.42583.F7","article-title":"Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast","volume":"16","author":"Palacios","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1390","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.MP.0000030450.20581.E3","article-title":"Clinical histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases","volume":"15","author":"Sneige","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1395","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2559.2001.01252.x","article-title":"Pleomorphic lobular carcinoma of the breast: its cell kinetics: expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas","volume":"39","author":"Frolik","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2016.05.002_bib1400","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-2559.2000.00810.x","article-title":"Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR","volume":"36","author":"Radhi","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2016.05.002_bib1405","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/00000478-200012000-00009","article-title":"Pleomorphic lobular carcinoma: morphology immunohistochemistry, and molecular analysis","volume":"24","author":"Middleton","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1410","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: american Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1415","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/path.2629","article-title":"The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type","volume":"220","author":"Weigelt","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1420","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1038\/onc.2013.277","article-title":"FER kinase promotes breast cancer metastasis by regulating alpha- and beta-integrin-dependent cell adhesion and anoikis resistance","volume":"32","author":"Ivanova","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2016.05.002_bib1425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1806","article-title":"Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity","volume":"207","author":"Reis-Filho","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1430","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/gcc.20756","article-title":"Positioning of necrotic lobular intraepithelial neoplasias (LIN: grade 3) within the sequence of breast carcinoma progression","volume":"49","author":"Boldt","year":"2010","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.prp.2016.05.002_bib1435","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","article-title":"Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ","volume":"44","author":"Shin","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1440","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/PAS.0b013e31817dc3a6","article-title":"Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile","volume":"32","author":"Chivukula","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2016.05.002_bib1445","series-title":"Stanzbioptische Mammapathologie im Mammographie-Screening","author":"Kreipe","year":"2015"},{"key":"10.1016\/j.prp.2016.05.002_bib1450","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/annonc\/mds280","article-title":"Genomic grade adds prognostic value in invasive lobular carcinoma","volume":"24","author":"Metzger-Filho","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1455","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jso.21121","article-title":"Is pleomorphic lobular carcinoma really a distinct clinical entity","volume":"98","author":"Buchanan","year":"2008","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.prp.2016.05.002_bib1460","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10549-013-2493-2","article-title":"Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast","volume":"138","author":"Arps","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2016.05.002_bib1465","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.amjsurg.2009.06.005","article-title":"Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal\/lobular breast cancers but differ from pure invasive ductal breast cancers","volume":"198","author":"Bharat","year":"2009","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.prp.2016.05.002_bib1470","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/1535-7163.MCT-14-1092","article-title":"Synthetic lethal screens identify vulnerabilities in GPCR signaling and cytoskeletal organization in E-cadherin-deficient cells","volume":"14","author":"Telford","year":"2015","journal-title":"Mol. Cancer Ther."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816300826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816300826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T07:06:20Z","timestamp":1718521580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033816300826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":294,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0344033816300826"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2016.05.002","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lobular breast cancer: Clinical, molecular and morphological characteristics","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}